Don't want to miss the best from Business Standard?
Strides Pharma Science (Strides) has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility between 16-20 January 2023. The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage formulation products across multiple dosage formats.
Powered by Capital Market - Live News
Make smarter market moves with The Smart Investor. Daily insights on buzzing stocks and actionable information to guide your investment decisions delivered to your inbox.
Disclaimer: No Business Standard Journalist was involved in creation of this content
